MedPath

evobupivacaine vs ropivacaine for labour analgesia

Not Applicable
Conditions
Health Condition 1: O80- Encounter for full-term uncomplicated delivery
Registration Number
CTRI/2020/11/028948
Lead Sponsor
nil
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

maternal request

sigleton term pregnancy with vertex presentation

ASA grade II

active stage of labour

Exclusion Criteria

allergy to any study drug

abnormal presentation

cephalopelvic disproportion

previous caesarean section

any medical complications

patients unwilling for labour analgesia

containdications to epidural anaesthesia

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
analgesic efficacy in terms of VAS 30Timepoint: From bolus to every 15 minutes till delivery
Secondary Outcome Measures
NameTimeMethod
maternal and fetal outcome <br/ ><br>maternal and obstetricians satisfaction <br/ ><br>side effect of any study drugTimepoint: during labour and 24 hours postpartum
© Copyright 2025. All Rights Reserved by MedPath